Combination Therapy

Radiolabeled compounds targeting the prostate-specific membrane antigen

PSMA binding ligand-linker conjugates and methods for using

PURIFICATION METHOD AND COMPOSITIONS

PSMA binding ligand-linker conjugates and methods for using

Methods for Synthesis of Radionuclide Complex

I DOMAIN CHIMERIC ANTIGEN RECEPTOR SPECIFIC TO ICAM-1

Method for extraction and purification of 68GA

LONG-CIRCULATING PSMA-TARGETED PHOTOTHERANOSTIC AGENT

MACROCYCLE CONJUGATES

Peptide compositions for immuno-oncology molecular imaging and targeted drug delivery

RADIOLABELED LIGANDS FOR TARGETED PET/SPECT IMAGING AND METHODS OF THEIR USE

Chiral cyclen compounds and their uses

Molecular probes and methods of use

POLYPEPT(O)ID-BASED GRAFT COPOLYMERS FOR IN VIVO IMAGING BY TETRAZINE TRANSYCLOOCTENE CLICK CHEMISTRY

METHOD

177-Lu LABELED PEPTIDE FOR SITE-SPECIFIC uPAR-TARGETING

Spatial mapping of kidney functions

Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte-stimulating hormone analogues for imaging or therapy

Anti-cancer agent comprising a tumour homing peptide having arsenic bonded to cysteine residues

Imaging methods using F-radiolabeled biologics

SITE-SPECIFIC RADIOFLUORINATION OF PEPTIDES WITH 8-[18F]-FLUOROOCTANOIC ACID CATALYZED BY LIPOIC ACID LIGASE

TRUNCATED CARTILAGE-HOMING PEPTIDES AND PEPTIDE COMPLEXES AND METHODS OF USE THEREOF

Modified antibody and radioactive metal-labelled antibody

HER2 binders

Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment

Methods and kits for preparing radionuclide complexes

Composition Containing a Somatostatin Analogue for Radiopharmaceutical Use

PSMA targeted radiotherapy medicine and preparation method thereof

Cyclic peptides as protein targeting agents

Cyclic compound/peptide comprising an A-beta13-16 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-beta13-16 peptide

Cyclic compound/peptide comprising an A-beta15-18 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-BETA15-18 peptide

Bicyclic peptide ligands with detectable moieties and uses thereof

PSMA binding ligand-linker conjugates and methods for using

Residualizing linkers and uses thereof

Radiopharmaceutical compositions

High affinity PD-1 agents and methods of use

Compositions comprising cyclic peptides derived from an A-beta peptide

CD8A-binding fibronectin type III domains

PSMA Imaging Agents

PSMA imaging agents

ATP1A1-TARGETING POLYPEPTIDE AND USE THEREOF

Peptide therapies for reduction of macular thickening

Methods for detecting CCR2 receptors

Cu(I)-catalyzed azide-alkyne cycloadditions (CuAAC) ligands and methods for carrying out Cu(I)-catalyzed azide-alkyne cycloaddition reactions

Method for labeling radioisotope, radiolabeling compounds using quinone compound and kit comprising the same for labeling radioisotope

RADIOLABELED PROGASTRIN IN CANCER DIAGNOSIS

PSMA imaging agents

CONJUGATABLE DESMOGLEIN 2 (DSG2) BINDING PROTEINS AND USES THEREFOR

CORROLE COMPOSITIONS

PROTEASE-ACTIVATED CONTRAST AGENTS FOR IN VIVO IMAGING

Copper-containing complex and uses thereof

PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING

TUMOUR-TARGETING PEPTIDE VARIANTS

Use of radiolabeled nanobody in prognosis and diagnosis of cancer

Positron emitting radionuclide labeled peptides for human uPAR PET imaging

Metal complex forming compound, metal complex compound formed thereof, radioactive drug containing the metal complex compound, and method of using and preparing the metal complex compound

PSMA binding ligand-linker conjugates and methods for using

Pharmaceutical compositions and preparations for administration to the eye

HYDROGEL-FORMING COMPOSITION FOR CONTROLLED RELEASE

Radioactive labeling method for neuropeptide Y derivative compound and medicine for multi-type breast cancer therapy thereof

Nucleophilic catalysts for oxime linkage

Substituted organofluoroborates as imaging agents

Renal-homing peptide conjugates and methods of use thereof

Immunomodulators

COMPOSITIONS AND REAGENTS FOR ION BEAM IMAGING

PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING

Transduced T cells expressing human SSTR2 and application thereof

PHTHALOCYANINE PROBES AND USES THEREOF

DUAL-TARGET IMAGING MOLECULAR PROBE, PREPARATION METHOD THEREFOR, AND APPLICATIONS THEREOF

PSMA binding ligand-linker conjugates and methods for using

PSMA binding ligand-linker conjugates and methods for using

KIT FOR LABELING A PROSTATE-SPECIFIC MEMBRANE ANTIGEN LIGAND WITH A RADIOACTIVE ISOTOPE

METHODS AND COMPOSITIONS FOR THE DETECTION OF CANCER

Radioactive labeled long-acting peptide targeted pharmaceutical and production method thereof

COMPOUNDS WITH REDUCED RING SIZE FOR USE IN DIAGNOSING AND TREATING MELANOMA, INCLUDING METASTATIC MELANOMA AND METHODS RELATED TO SAME

HER3 peptides for imaging and radiotherapy

Enhanced in vivo targeting of radiolabelled peptides with the means of enzyme inhibitors

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

Radiotherapeutic and companion imaging agents to target MC1R

Modified variable domain molecules and methods for producing them

Tumor targeted radionuclide therapy and molecular imaging of HER2+ cancers and other neoplasms

Caspase-3-triggered molecular self-assembling PET probes and uses thereof

PRECISION MEDICINE THERANOSTICS AND DIAGNOSTICS A COMBINATION THEREOF

Method for labeling of sensitive and thermosensitive targeting biomolecules with technetium based compounds

Compounds that bind to human immunodeficiency virus rev response element

Tumor treatment methods using cells that localize to the tumor

COMPOSITIONS AND METHOD FOR THE TREATMENT AND DETECTION OF COLON CANCER

I domain chimeric antigen receptor specific to ICAM-1

Radiolabeled GRPR-antagonists for diagnostic imaging and treatment of GRPR-positive cancer

Imaging agents and uses thereof

Modulation of immunity and CEACAM1 activity

Bioresponsive particles

Kit for radiolabelling

177-LU LABELED ACTIVE SITE INHIBITED FACTOR VII

Compositions and methods for cancer imaging and radiotherapy

PD-L1 binding polypeptides for imaging

Peptides useable for treatment of disorders of the eye

Treatment of cancer cells overexpressing somatostatin receptors using ocreotide derivatives chelated to radioisotopes

Alpha(v)beta(6) integrin-binding peptides and methods of use thereof

Peptide-Mediated Non-Covalent Delivery of Active Agents Across the Blood-Brain Barrier

PET tracer for imaging of neuroendocrine tumors

AGENTS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF DISEASES ASSOCIATED WITH EXTRACELLULAR MATRIX TURNOVER

Tumor and immune cell imaging based on PD-L1 expression

Peptides useable for treating cancer

PRODUCTION OF 43SC RADIONUCLIDE AND ITS USE IN POSITRON EMISSION TOMOGRAPHY

Compositions for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same

FORMULATIONS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING

Inhibitor-functionalized ultrasmall nanoparticles and methods thereof

Methylglyoxal-scavenging cyclic peptides and their use for the prevention and treatment of diseases associated with elevated methylglyoxal levels

Methods for the iodination of biomolecules

Radiotracer compositions and methods

Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells

Kinase and/or phosphatase sensing via hydroxyquinoline-sensitized chelates

HER2 binders

Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment

One step 64Cu-BaBaSar-RGD2 production method

IMAGING SYSTEMS AND METHODS FOR PARTICLE-DRIVEN, KNOWLEDGE-BASED, AND PREDICTIVE CANCER RADIOGENOMICS

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

ANTICANCER THERAPY

Imaging methods using 18F-radiolabeled biologics

PET imaging with PD-L1 binding polypeptides

Predicting peptide receptor radiotherapy using a gene expression assay

METHODS OF MAKING 18F-LABELED PRECURSORS AND PEPTIDES, LABELED C-MET BINDING PEPTIDES, AND METHODS OF USE THEREOF

Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide

Retro-inverso peptide inhibitors of cell migration, extracellular matrix and endothelial invasion by tumor cells

METHODS AND COMPOSITIONS FOR DETECTING ANEURYSMS

PET-imaging immunomodulators

Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same

CD31 as a molecular target for imaging of inflammation

Chemical conjugates of evans blue derivatives and their use as radiotherapy and imaging agents

PET tracer for imaging of neuroendocrine tumors

Therapeutic inhibitor for EBV-associated tumor with tailor responsive optical imaging

NOVEL POLYPEPTIDES WITH IMPROVED PROTEOLYTIC STABILITY, AND METHODS OF PREPARING AND USING SAME

QUANTITATIVE PET IMAGING OF TISSUE FACTOR EXPRESSION USING 18F-LABLED ACTIVE SITE INHIBITED FACTOR VII

Process for producing Gallium-68 through the irradiation of a solution target

Compositions and methods for treatment and imaging using nanoparticles

Bicyclic peptide ligands with detectable moieties and uses thereof

Cyclic NTCP-targeting peptides and their uses as entry inhibitors

Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide

Therapeutic and Diagnostic Probes

Systems and methods for minimally-invasive assessment of toxicity-induced tissue injury

Methods and compositions for 18F-radiolabeling of biologics

Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide

METHODS FOR PREPARING HIGH THROUGHPUT PEPTIDOMIMETICS, ORALLY BIOAVAILABLE DRUGS AND COMPOSITIONS CONTAINING SAME

Kinin-based theranostic probes for solid cancers and uses thereof

Method

Conjugates of RGD peptides and (bacterio)chlorophyll photosensitizers

PSMA binding ligand-linker conjugates and methods for using

PHARMACEUTICAL FORMULATION AND METHOD OF PREPARING THE SAME

Compounds having RD targeting motifs and methods of use thereof

PSMA binding ligand-linker conjugates and methods for using

PSMA binding ligand-linker conjugates and methods for using

PSMA binding ligand-linker conjugates and methods for using

Methods for low temperature fluorine-18 radiolabeling of biomolecules

PSMA binding ligand-linker conjugates and methods for using

PSMA binding ligand-linker conjugates and methods for using

PSMA binding ligand-linker conjugates and methods for using

Kit for radiolabelling

Core constructs and their uses in configuring pharmaceutical molecules

PSMA imaging agents

EpCAM targeted polypeptides, conjugates thereof, and methods of use thereof

PSMA binding ligand-linker conjugates and methods for using

Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof

Quantifying Net Axonal Transport in Motor Neuron Pathologies

CCK2R-drug conjugates

CONTRAST-AGENT-LABELED PEPTIDE AMPHIPHILE NANOFIBERS

Environmentally sensitive compositions comprising a pH-triggered membrane protein and methods of use thereof in the treatment and diagnosis of tumors

Conjugates that are configured for targeted delivery of therapeutic compounds to senescent cells

POSITRON EMITTING RADIONUCLIDE LABELED PEPTIDES FOR HUMAN UPAR PET IMAGING

Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to RGD binding sites

CEACAM1 BASED CANCER THERAPY AND DIAGNOSIS

CEACAM1 MEDIATED PROTECTIVE IMMUNITY

CD8a-binding fibronectin type III domains

Radiolabeled GRPR-Antagonists For Diagnostic Imaging and Treatment of GRPR-Positive Cancer

RADIOTHERAPEUTIC AND COMPANION IMAGING AGENTS TO TARGET MC1R

Radiolabeled active targeting pharmaceutical composition and the use thereof

Molecular probes and methods of use

Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells

METHODS AND KITS FOR PREPARING RADIONUCLIDE COMPLEXES

Immunomodulators

Transduced T cells expressing human SSTR2 and application thereof

I domain chimeric antigen receptor specific to ICAM-1

METHODS OF TREATING CANCER WITH A PSMA LIGAND-TUBULYSIN COMPOUND

Homing agents

Somatostatin receptor-based cancer therapy

CANCER IMAGING AGENT

TUBULYSIN CONJUGATE FOR USE IN TREATING CANCER

Anticancer therapy

Angiopep and derivatives thereof for imaging amyloids

Therapeutic inhibitor for EBV-associated tumor with tailor responsive optical imaging

Cu(I)-catalyzed azide-alkyne cycloadditions (CuAAC) ligands and methods for carrying out Cu(I)-catalyzed azide-alkyne cycloaddition reactions

Radiopharmaceutical conjugate of a metabolite and an EPR agent, for targeting tumour cells

GRP78 TARGETED CONJUGATES

METHODS OF TREATING CANCER WITH TUBULYSIN CONJUGATES

Peptides for diagnosis and treatment of cancer

ENDOSOMAL ESCAPE DOMAINS FOR DELIVERY OF MACROMOLECULES INTO CELLS

Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imaging

Subcutaneous administration of anti-CD74 antibody for systemic lupus erythematosus

Stable compositions of high-concentration allotype-selected antibodies for small-volume administration

Chlorotoxin polypeptides and conjugates and uses thereof

PD-L1 binding polypeptides for imaging

PSMA binding ligand-linker conjugates and methods for using

MODIFIED VARIABLE DOMAIN MOLECULES AND METHODS FOR PRODUCING THEM

High affinity PD-1 agents and methods of use

CARBOHYDRATE FUNCTIONALIZED CATANIONIC SURFACTANT VESICLES FOR DRUG DELIVERY

Compositions targeting radiation-induced molecules and methods of use thereof

Cage-like bifunctional chelators, copper-64 radiopharmaceuticals and PET imaging using the same

Bladder cancer specific ligand peptides

NANOCARRIERS FOR CANCER TREATMENT

Peptide-mediated non-covalent delivery of active agents across the blood-brain barrier

PROLACTIN RECEPTOR ANTAGONISTS FOR TREATMENT OF GLIOBLASTOMA

Nanoparticles and method for manufacturing the same

Conjugate comprising a neurotensin receptor ligand and use thereof

Multidentate bifunctional chelating agents for radionuclide complexation in diagnostics and therapy

CYCLIC PEPTIDES AND USES THEREOF

Production of 43SC radionuclide and radiopharmaceuticals thereof for use in positron emission tomography

Drug conjugates for delivering compounds to senescent cells

Targeting of chondroitin sulfate glycans

Pharmaceuticals in joint-linker configurations for treating pathological blood clots

Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof

RADIOCONJUGATION METHOD

Peptides whose uptake by cells is controllable

Targeting of chondroitin sulfate glycans

Compounds for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same

PROCESS FOR PRODUCING GALLIUM-68 THROUGH THE IRRADIATION OF A SOLUTION TARGET

Tumor-targeting polypeptide and application thereof

Cage amine ligands for metallo-radiopharmaceuticals

Activatable fibrin-binding probes

COMPOSITIONS FOR RADIOTHERAPY AND USES THEREOF

PSMA imaging agents

Radiotracer compositions and methods

PURIFICATION METHOD AND COMPOSITIONS

Dendrimer compositions, methods of synthesis, and uses thereof

18F-Labelled Aldehyde Compositions for Radiofluorination

Residualizing linkers and uses thereof

Positron emitting radionuclide labeled peptides for human uPAR PET imaging

Process for the preparation of complexes of Ga

Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity

Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment

Environmentally sensitive compositions and methods of use thereof

Transmetalation methods for the synthesis of PET and SPECT imaging agents

DELIVERY SYSTEM FOR CYTOTOXIC DRUGS BY BISPECIFIC ANTIBODY PRETARGETING

Compounds that bind to human immunodeficiency virus rev response element

Spect radionuclide-labeled trimeric cycle RGD peptide, preparation method thereof and imaging method thereof

Agents for the Molecular Imaging of Serine-Protease in Human Pathologies

Molecular constructs for treating tumors

Ligands to radiation-induced molecules

HER2 binders

Nitrogen-containing compound or salt thereof, or metal complex thereof

Multimodal imaging of fibrin

Conjugates for imaging

Labeled ligands of anti-Mullerian hormone for diagnosis of endometriosis

Chlorotoxin polypeptides and conjugates and uses thereof

PSMA binding ligand-linker conjugates and methods for using

PEPTIDES USEFUL AS CELL-PENETRATING PEPTIDES

Compositions and Imaging Methods Comprising Detectably Labeled Phosphatidylethanolamine-Binding Peptides

Compounds for binding to the platelet specific glycoprotein IIb/IIIa and their use for imaging of thrombi

GRP-R agonistic 177-lutetium-labeled bombesin derivatives for diagnosis and treatment of prostate cancer

Method of diagnosing and treating Alzheimer's disease

Clinical Multimodality-Tools for Pre-And Intraoperative Insulinoma Diagnostics

Prosthetic compounds for labeling internalizing biomolecules

METAL COMPLEXES AND THEIR FLUORINATION

Detection of early-stage pancreatic adenocarcinoma

PSMA binding ligand-linker conjugates and methods for using

SHK-based pharmaceutical compositions and methods of manufacturing and using the same

Complex of mannosyl serum albumin, method of preparing the same, optical imaging probe and kit comprising the same

Substituted organofluoroborates as imaging agents

RHAMM binding peptides

Radiotracer compositions

Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to RGD binding sites

Vinylsulfone-based 18F-labeling compositions and methods and uses thereof

Metallocene compounds and labeled molecules comprising the same for in vivo imaging

Methods and compositions for radiohalogen protein labeling

Compositions and methods for detecting plectin-1 as a biomarker for cancer

Conjugates derived from non-steroidal anti-inflammatory drugs and methods of use thereof in imaging

Phthalocyanine probes and uses thereof

INTRAOPERATIVE DETECTION OF TUMOR RESIDUES USING BETA-RADIATION AND CORRESPONDING PROBES

Compositions and methods for treatment and imaging using nanoparticles

Class I anti-CEA antibodies and uses thereof

Therapeutic and diagnostic probes

Biomolecule labeling reaction container, and reactor and reaction method using the same

Antibodies reactive with an epitope located in the N-terminal region of MUC5AC comprising cysteine-rich subdomain 2 (Cys2)

PEPTIDIC STRUCTURES INCORPORATING AN AMINO ACID METAL COMPLEX AND APPLICATIONS IN MAGNETIC RESONANCE IMAGING

Conjugates of proteins and multivalent cell-penetrating peptides and their uses

Tetraaza macrocyclic compound, preparation method thereof and use thereof

BOMBESIN ANALOG PEPTIDE ANTAGONIST CONJUGATES

Radiolabeled GRPR-antagonists for diagnostic imaging and treatment of GRPR-positive cancer

Method to improve the tumor diagnostic efficiency of multivalent ligands by regulating the stoichiometric ratio between inner surface functionalities and ligand moieties for tumor targeting

Methods of Synthesizing and Using Peg-Like Fluorochromes

HER3 binding polypeptides

Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same

Compositions targeting bradykinin receptor B1 for medical imaging of cancer and other disorders

Radiolabeled active targeting pharmaceutical composition and the use thereof

AL-F-18-LABELED, AL-F-19-LABELED AND GA-68-LABELED GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR)-ANTAGONISTS FOR IMAGING OF PROSTATE CANCER

Targeted molecular imaging probe and method for in vivo molecular imaging

Anticancer therapy